118th Congress Health
H.R. 235: Triple-Negative Breast Cancer Research and Education Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.
Specifically, the National Institutes of Health must conduct and support research into the disease.
Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Gwen Moore D-WI
- Don Bacon R-NE
- Joseph Morelle D-NY
- Paul Tonko D-NY
- Nikema Williams D-GA
- Glenn Ivey D-MD
- Dwight Evans D-PA
- Troy Carter D-LA
- Jonathan Jackson D-IL
- Jared Moskowitz D-FL
- Sheila Cherfilus-McCormick D-FL
- Terri Sewell D-AL
Who scored on this bill
- 1Sheila Jackson Lee SponsorIntroduced, drew cross-party cosponsors2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Sheila Jackson Lee
History
- Introduced in the House by Sheila Jackson Lee.
Show the full action history (3 actions)
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the House Committee on Energy and Commerce.